Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Maura

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Blood Cancer Journal|May 1, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patientsRoss S Firestone, Anish K Simhal, Theresia Akhlaghi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Nature Communications|August 24, 2018
Genomic patterns of progression in smoldering multiple myelomaNiccolò Bolli, Francesco Maura, Stephane Minvielle, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Blood Cancer Journal|April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myelomaHamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Blood Cancer Journal|May 1, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patientsRoss S Firestone, Anish K Simhal, Theresia Akhlaghi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Nature Communications|August 24, 2018
Genomic patterns of progression in smoldering multiple myelomaNiccolò Bolli, Francesco Maura, Stephane Minvielle, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Blood Cancer Journal|April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myelomaHamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Pageof 15